BPA Call 75F40121A00001-75F40123F19003
Award Date 8/25/23
Potential Completion Date 9/3/26
Potential Value $7.5M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Arlington, VA 22203, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Food and Drug Administration (FDA) to Accenture Federal Services LLC, a subsidiary of the global professional services firm Accenture, to provide business transformation team (BTT) support services. The contract has a ceiling value of $6,333,945.13 and runs through June 24, 2026. It was awarded on September 21, 2023 and is a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract vehicle. The contract does not have a...
- This is a federal contract award from the Food and Drug Administration (FDA) to Accenture Federal Services LLC, doing business as Accenture National Security Services, for $6,476,688.66 over a two-year period ending on August 9, 2024. The contract, which is a Blanket Purchase Agreement (BPA) call placed under Accenture's existing Multiple Award Schedule (MAS) contract, is for scientific and operational support services for the FDA's Center for Drug Evaluation and Research (CDER). The contract is...
- This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Accenture Federal Services LLC, a global professional services company. The contract focuses on evaluating the current state of the FDA's submission process and implementing a series of iteratively designed, developed, and tested capabilities. The contract is a definitive, time and materials contract with a potential value of $1,893,888.50 and a completion date of September...
- Accenture Federal Services LLC was awarded a Business Transformation Team (BTT) Support Services contract by the Food and Drug Administration on July 30, 2021, under a Blanket Purchase Agreement (BPA) call with a ceiling value of $36.3 million and a completion date of February 13, 2026. The contract, which uses time and materials pricing and carries no set-aside designation, is performed in Calverton, Maryland. As a subsidiary of the global professional services firm Accenture plc, Accenture...
- The Food and Drug Administration awarded a $6.36 million delivery order to Accenture Federal Services LLC for Center for Drug and Radiological Health (CDRH) Business Process Improvement Support Services. Issued on September 28, 2020, with completion by September 3, 2023, this firm fixed-price delivery order was executed under the General Services Administration's Multiple Award Schedule contract vehicle. The work is to be performed in Arlington, Virginia. No small business set-aside was...
- This is a $2,587,360.14 delivery order contract awarded to Accenture Federal Services LLC by the Food and Drug Administration (FDA). The contract is for enterprise data governance services for the FDA's Center for Drug Evaluation and Research (CDER) and uses the Alliant II Government-Wide Acquisition Contract (GWAC) as the parent contract vehicle. The contract has a period of performance that runs through February 24, 2025 and is on a time and materials pricing basis. Accenture Federal Services,...
- This federal contract was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Accenture Federal Services LLC, a global professional services firm, to support the Center for Drug Evaluation and Research's (CDER) IT operations and strategy. The $7,004,449.10 contract, which is not set aside, consists of three work streams focused on program management, IT strategy development, and oversight to ensure proper planning and management of CDER's IT initiatives....
- This federal contract award, issued by the Food and Drug Administration (FDA), is a Blanket Purchase Agreement (BPA) call with Accenture Federal Services LLC to provide program management support for the FDA's Enterprise Transformation Office (ETO). The purpose is to support the ETO's objectives in driving business process changes across the agency. The contract has a ceiling value of $4,351,414.94 and a period of performance through June 12, 2024. It utilizes labor hours as the pricing type....
- The U.S. Food and Drug Administration (FDA) awarded a $3,629,755 firm-fixed-price definitive contract to Accenture Federal Services LLC, a subsidiary of the global professional services firm Accenture plc, to develop a cloud-based transnational regulatory platform for multi-region regulatory collaboration. This contract is not set aside for any specific business size or socioeconomic category. The contract award is derived from the FDA's Fiscal Year 2024 Broad Agency Announcement (BAA) for...
- The Food and Drug Administration awarded a Clinical Data Safety Analysis contract to Accenture Federal Services LLC on April 23, 2025, with an ultimate completion date of April 27, 2027. This Firm Fixed Price Blanket Purchase Agreement call, valued at $1.89M, will be performed in Arlington, Virginia. The contract will support FDA's critical mission of ensuring the safety and efficacy of drugs, medical devices, and other FDA-regulated products through comprehensive clinical data analysis....